REQUEST A DEMO
Total
USD $0.00
Search more companies

NeoImmuneTech. Inc. (South Korea)

Main Activities: Biological Product (except Diagnostic) Manufacturing
Full name: NeoImmuneTech. Inc. Profile Updated: May 15, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

NeoImmuneTech. Inc. is based in South Korea. The head office is in Brockville, Ontario. It operates in the Biological Product (except Diagnostic) Manufacturing sector. It was established on January 29, 2014. 40 (2025) employees currently work for NeoImmuneTech. Inc.. There was a net sales revenue drop of 44.15% reported in NeoImmuneTech. Inc.’s latest financial highlights for 2025. Over the same period, its total assets grew by 25.45%. The net profit margin of NeoImmuneTech. Inc. decreased by 9388.76% in 2025.

Headquarters
2400 Research Boulevard, Suite 250
Brockville, Ontario;

Contact Details: Purchase the NeoImmuneTech. Inc. report to view the information.

Website: http://neoimmunetech.co.kr

Basic Information
Total Employees:
Purchase the NeoImmuneTech. Inc. report to view the information.
Outstanding Shares:
Purchase the NeoImmuneTech. Inc. report to view the information.
Registered Capital:
Purchase the NeoImmuneTech. Inc. report to view the information.
Financial Auditors:
Purchase the NeoImmuneTech. Inc. report to view the information.
Incorporation Date:
January 29, 2014
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Financial Officer
Ownership Details
Purchase this report to view the information.
5.7%
Purchase this report to view the information.
0.13%
Purchase this report to view the information.
0.1%
Subsidiaries
Neoimmunetech, Inc.
100%
Company Performance
Financial values in the chart are available after NeoImmuneTech. Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-44.15%
Total Operating Revenue
-14.35%
Operating Profit
40.17%
EBITDA
41.55%
Net Profit/Loss for the Period
22.28%
Total Assets
25.45%
Total Equity
42.18%
Operating Profit Margin
-1768.64%
Net Profit Margin
-9388.76%
Return on Equity (ROE)
51.58%
Debt / Equity
-8.13%
Quick Ratio
1.19%
Cash Ratio
0.24%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?